Douglas Cowart
Fondatore presso Cardioxyl Pharmaceuticals LLC
Provenienza dei contatti di primo grado di Douglas Cowart
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Nometics, Inc.
 Nometics, Inc. Pharmaceuticals: MajorHealth Technology Nometics, Inc. operates as a specialty pharmaceutical company. It focuses on the treatment of cancer through the restoration of the nitric oxide signaling pathway. The company is headquartered in Toronto, Canada.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Douglas Cowart tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
HyperBranch Medical Technology, Inc.
 HyperBranch Medical Technology, Inc. Medical SpecialtiesHealth Technology HyperBranch Medical Technology, Inc. develops and markets biosurgical devices. It develops and markets products primarily for the traumatic or surgically induced wound market. The firm offers Adherus AutoSpray Dural Sealant which is a synthetic, absorbable, two-component dural sealant indicated for use in patients as an adjunct to standard methods of dural repair. The company was founded by Mark W. Grinstaff and Anthony J. Sherbondy in March 2003 and is headquartered in Durham, NC. | Medical Specialties | Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Corporate Officer/Principal | |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| University of Connecticut | College/University | Doctorate Degree Doctorate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Graduate Degree Doctorate Degree | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Founder Director/Board Member | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Neotropix, Inc.
 Neotropix, Inc. BiotechnologyHealth Technology Neotropix, Inc. develops virus-based therapies for cancer treatment. It has developed NTX-010 virus, a small cell lung cancer treatment and as a treatment of pediatric cancers, such as neuroblastoma. The company was founded by Paul L. Hallenbeck in 2003 and is headquartered in Malvern, PA. | Biotechnology | Director/Board Member Director/Board Member | |
| Bethesda Research Laboratories, Inc. | Chief Executive Officer | ||
| IOMAI CORPORATION | Biotechnology | Director/Board Member | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chairman | |
| ECHO GLOBAL LOGISTICS, INC. | Trucking | Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Founder | |
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Duke University Health System, Inc.
 Duke University Health System, Inc. Medical/Nursing ServicesHealth Services Duke University Health System, Inc. engages in the provision of health care services. It offers cancer treatment, primary care, orthopedics, aesthetics, and fertility services. The company was founded in 1998 and is headquartered in Durham, NC. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| St. Lawrence University | College/University | Undergraduate Degree | |
| Vanderbilt University | College/University | Doctorate Degree | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Chairman | |
| Boston College | College/University | Undergraduate Degree | |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
| University of Tennessee | College/University | Doctorate Degree | |
| Santa Clara University | College/University | Masters Business Admin | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
| NEA 13 GP Ltd. | Director/Board Member | ||
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member | |
| NEA 12 GP LLC | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 50 |
| Regno Unito | 2 |
Settori
| Health Technology | 31 |
| Consumer Services | 9 |
| Finance | 3 |
| Health Services | 3 |
| Transportation | 2 |
Posizioni
| Director/Board Member | 96 |
| Corporate Officer/Principal | 39 |
| Independent Dir/Board Member | 27 |
| Founder | 19 |
| Chairman | 19 |
Contatti più connessi
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Peter Thompson | 39 |
| Jeff Bank Clark | 20 |
| Chris Kroeger | 15 |
| Peter David Suzdak | 12 |
| Robert J. Garland | 12 |
| James C. Gilbert | 9 |
| Kimberly McCutcheon Jablonski | 8 |
| Gary L. Stiles | 7 |
| John E. Reardon | 6 |
| Ronald Borchardt | 6 |
| Vincent J. Kalish | 6 |
| Shi Yin Foo | 5 |
| Reza Mazhari | 4 |
| Robert Bender | 3 |
- Borsa valori
- Insiders
- Douglas Cowart
- Connessioni Società
